582 results on '"Akiyama F"'
Search Results
2. Technical note: The use of a physical activity monitor to estimate the eating time of cows in pasture
3. Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells
4. Do Sprouting Tree Species on Erosion-prone Sites Carry Large Reserves of Resources?
5. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway
6. Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy
7. 5MO Evaluation of pathological complete response (pCR) after neoadjuvant chemo-radiation therapy for primary breast cancer (JCOG0306A1)
8. PIK3CA mutations and predicting the therapeutic effects of neoadjuvant chemotherapy in primary breast cancer
9. 180P Development of prognosis prediction model using cytokeratin 19 mRNA copy number of sentinel lymph node metastasis in breast cancer: A multicenter study in Japan
10. Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer
11. Expression of oestrogen receptor-β in apocrine carcinomas of the breast
12. CIH-Tokyo Experience with Breast-Conserving Surgery without Radiotherapy: 6.5 Year Follow-Up Results of 1462 Patients
13. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast
14. Transforming growth factor-β1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy
15. Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status
16. In vitro evaluation of Er:YAG laser scaling of subgingival calculus in comparison with ultrasonic scaling
17. Abstract P5-18-11: Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situof the breast
18. Abstract P4-08-29: Lymphatic invasion is an independent risk factor in patients with small node-negative luminal breast cancer
19. Abstract P3-03-23: Which factor of metastatic lymph nodes–The number, tumor volume or anatomical location–Is independently prognostic in breast cancer? - A prospective cohort study using molecular whole-node analysis of all removed axillary nodes
20. Section 5. Breast: Breast conserving treatment without radiotherapy
21. Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer
22. Abstract P2-06-02: Breast cancer HER2 epigenetic intratumoral heterogeneity results from lack of HER2 protein translation
23. 286 Poster - PIK3CA mutations and predicting the therapeutic effects of neoadjuvant chemotherapy in primary breast cancer
24. Predictive factors and value of ypN+ after neoadjuvant chemotherapy in clinically lymph node-negative breast cancer
25. Lymphatic invasion is significantly associated with prognosis in patients with node-negative early luminal breast cancer
26. Treatment outcomes of stage IIIC breast cancer: a single institutional review
27. Construction of a nomogram, based on one-step nucleic acid amplification, for prediction of non-sentinel node metastasis in breast cancer patients with sentinel node metastasis
28. Abstract P1-03-08: Simultaneous analyses of HER2 gene and protein status can more precisely predict pathological complete response (pCR) to neoadjuvant trastuzumab with chemotherapy in primary HER2-positive breast cancer
29. Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer
30. 65PD Significance of preoperative fine-needle aspiration biopsy for suspected cases of lymph node metastasis in primary breast cancer
31. 89P Questionnaire survey on patients’ preference for orally disintegrating tablets or granules of S-1 in postoperative adjuvant treatment for breast cancer
32. Clinical Outcome and Prognostic Factors in Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Followed by Surgery and Postmastectomy Radiation Therapy
33. Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer
34. EP-1164: Outcomes of postmastectomy radiotherapy in patients with 1 to 3 positive nodes in single institute
35. Abstract P4-02-13: The pattern of tumor shrinkage is associated with prognosis in low grade luminal early breast cancer during neoadjuvant chemotherapy
36. 511 (PB-144) - Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer
37. P325 Lymphedema incidence over time with sentinel lymph node dissection alone of Japanese women
38. P300 - Construction of a nomogram, based on one-step nucleic acid amplification, for prediction of non-sentinel node metastasis in breast cancer patients with sentinel node metastasis
39. P196 - Lymphatic invasion is significantly associated with prognosis in patients with node-negative early luminal breast cancer
40. P210 - Predictive factors and value of ypN+ after neoadjuvant chemotherapy in clinically lymph node-negative breast cancer
41. P134 - Treatment outcomes of stage IIIC breast cancer: a single institutional review
42. Short communication: Effect of grazing on the concentrations of total sialic acid and hexose in bovine milk
43. Corrigendum to ‘Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles’ [Biomaterials 34 (2013) 9220–9226]
44. 244P - Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer
45. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort
46. Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.
47. Abstract P2-02-11: Accuracy of MRI and ultrasonography in predicting pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy
48. Abstract P2-18-03: Feasibility of sentinel node biopsy following neoadjuvant chemotherapy in cytology-proven node positive breast cancer before chemotherapy
49. Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay
50. Reply: Isolated tumour cells and micrometastases in intraductal breast cancer: a simple mechanical question in some cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.